Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
Urban Company Limited Launches ‘Revamp’: Transform Any Wall, Any Space in a Day
MUMBAI, India, Aug. 27, 2025 /PRNewswire/ -- Urban Company Limited today announced the…
Novo Nordisk A/S: Wegovy approved in the US for the treatment of MASH
Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US…
Spineway : H1 2025 results – Continued improvement in results and financial position
Press release Ecully, July 30, 2025 – 7 p.m. SPINEWAY H1 2025…
MR.DIY Announces Rajkummar Rao as the Brand Ambassador with their ‘Milega kya, Mat Pooch – MR.DIY has Sabkuch’ campaign
Campaign film link: https://www.instagram.com/reel/DLrGKtyosho/?igsh=bDVibnN3MWgzYmc= MUMBAI, India, July 4, 2025 /PRNewswire/ -- MR.DIY,…
Dupixent (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color…
GRVT Introduces Retail Price Improvement Orders, Bringing Proven TradFi Execution Benefits Onchain
SINGAPORE, June 4, 2025 /PRNewswire/ -- GRVT, the world's first licensed onchain…
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
TTFields therapy concomitant with gemcitabine and nab-paclitaxel is the first treatment to…
